Literature DB >> 20840266

Congenital cytomegalovirus infection.

Angeliki Syggelou1, N Iacovidou, S Kloudas, Z Christoni, V Papaevangelou.   

Abstract

Congenital cytomegalovirus (CMV) infection is a serious health problem. The obstacles for limiting this infection are the lack of public awareness on this issue, especially owing to the asymptomatic nature of CMV infections, the inefficacy of therapy, and the unsuccessful vaccine trials to date. It is therefore important to organize the current data to estimate the results and to report that the development of a vaccine against CMV must be of the highest priority.
© 2010 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2010        PMID: 20840266     DOI: 10.1111/j.1749-6632.2010.05649.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  The unique immunological and microbial aspects of pregnancy.

Authors:  Gil Mor; Paulomi Aldo; Ayesha B Alvero
Journal:  Nat Rev Immunol       Date:  2017-06-19       Impact factor: 53.106

Review 2.  The role of trophoblastic microRNAs in placental viral infection.

Authors:  Jean-Francois Mouillet; Yingshi Ouyang; Avraham Bayer; Carolyn B Coyne; Yoel Sadovsky
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 3.  Parasite dissemination and the pathogenesis of toxoplasmosis.

Authors:  L M Randall; C A Hunter
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

Review 4.  Viral infections during pregnancy.

Authors:  Michelle Silasi; Ingrid Cardenas; Ja-Young Kwon; Karen Racicot; Paula Aldo; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2015-01-13       Impact factor: 3.886

5.  Complex expression of the UL136 gene of human cytomegalovirus results in multiple protein isoforms with unique roles in replication.

Authors:  Katie Caviness; Louis Cicchini; Michael Rak; Mahadevaiah Umashankar; Felicia Goodrum
Journal:  J Virol       Date:  2014-10-08       Impact factor: 5.103

6.  Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency.

Authors:  Shu Cheng; Katie Caviness; Jason Buehler; Megan Smithey; Janko Nikolich-Žugich; Felicia Goodrum
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-20       Impact factor: 11.205

7.  Antagonistic determinants controlling replicative and latent states of human cytomegalovirus infection.

Authors:  Mahadevaiah Umashankar; Michael Rak; Farah Bughio; Patricia Zagallo; Katie Caviness; Felicia D Goodrum
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

8.  Characterization of human cytomegalovirus UL145 and UL136 genes in low-passage clinical isolates from infected Chinese infants.

Authors:  Bo Wang; Jing-Jing Hu; Cui-Fang Yan; Hai-Hao Su; Jun-Cai Ding; Yuan-Yuan Guo; Ning Ye; Shui-Qing Zhang; Xiao-Zhuang Zhang; Shu-Feng Zhou
Journal:  Med Sci Monit       Date:  2011-08

9.  A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection.

Authors:  Mahadevaiah Umashankar; Alex Petrucelli; Louis Cicchini; Patrizia Caposio; Craig N Kreklywich; Michael Rak; Farah Bughio; Devorah C Goldman; Kimberly L Hamlin; Jay A Nelson; William H Fleming; Daniel N Streblow; Felicia Goodrum
Journal:  PLoS Pathog       Date:  2011-12-29       Impact factor: 6.823

10.  Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011.

Authors:  W Wujcicka; Z Gaj; J Wilczyński; W Sobala; E Spiewak; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.